NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 261 filers reported holding NATERA INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,476,283 | +14.5% | 259,351 | +25.9% | 0.00% | 0.0% |
Q2 2023 | $10,019,922 | -43.2% | 205,917 | -35.2% | 0.00% | -50.0% |
Q1 2023 | $17,636,371 | +110.7% | 317,658 | +52.5% | 0.00% | +100.0% |
Q4 2022 | $8,369,339 | +6.2% | 208,348 | +15.9% | 0.00% | 0.0% |
Q3 2022 | $7,879,000 | -8.3% | 179,821 | -25.8% | 0.00% | 0.0% |
Q2 2022 | $8,590,000 | -43.7% | 242,381 | -35.4% | 0.00% | 0.0% |
Q1 2022 | $15,264,000 | -35.8% | 375,216 | +47.4% | 0.00% | -50.0% |
Q4 2021 | $23,765,000 | -31.9% | 254,471 | -18.7% | 0.00% | -50.0% |
Q3 2021 | $34,895,000 | -8.7% | 313,122 | -7.0% | 0.00% | 0.0% |
Q2 2021 | $38,231,000 | +5.4% | 336,746 | -5.8% | 0.00% | 0.0% |
Q1 2021 | $36,283,000 | +18.3% | 357,316 | +16.0% | 0.00% | 0.0% |
Q4 2020 | $30,659,000 | +76.2% | 308,068 | +27.9% | 0.00% | +100.0% |
Q3 2020 | $17,397,000 | +11.4% | 240,824 | -23.1% | 0.00% | 0.0% |
Q2 2020 | $15,621,000 | +92.1% | 313,296 | +15.1% | 0.00% | +100.0% |
Q1 2020 | $8,130,000 | +1.6% | 272,261 | +14.7% | 0.00% | 0.0% |
Q4 2019 | $7,999,000 | +3.6% | 237,423 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $7,721,000 | +5.3% | 235,407 | -11.4% | 0.00% | 0.0% |
Q2 2019 | $7,329,000 | +43.1% | 265,773 | +7.0% | 0.00% | 0.0% |
Q1 2019 | $5,123,000 | +125.5% | 248,440 | +52.7% | 0.00% | – |
Q4 2018 | $2,272,000 | -49.8% | 162,741 | -13.9% | 0.00% | -100.0% |
Q3 2018 | $4,528,000 | +106.4% | 189,108 | +62.2% | 0.00% | – |
Q2 2018 | $2,194,000 | +151.6% | 116,568 | +23.9% | 0.00% | – |
Q1 2018 | $872,000 | +17.0% | 94,070 | +13.5% | 0.00% | – |
Q4 2017 | $745,000 | -52.5% | 82,869 | -31.9% | 0.00% | – |
Q3 2017 | $1,570,000 | +86.0% | 121,770 | +56.9% | 0.00% | – |
Q2 2017 | $844,000 | +40.0% | 77,630 | +14.2% | 0.00% | – |
Q1 2017 | $603,000 | +45.0% | 67,977 | +91.2% | 0.00% | – |
Q4 2016 | $416,000 | +14.6% | 35,549 | +8.7% | 0.00% | – |
Q3 2016 | $363,000 | +1810.5% | 32,700 | +1933.6% | 0.00% | – |
Q2 2016 | $19,000 | +533.3% | 1,608 | +564.5% | 0.00% | – |
Q4 2015 | $3,000 | -83.3% | 242 | -85.2% | 0.00% | – |
Q3 2015 | $18,000 | – | 1,637 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |